PAI Partners to acquire Nuzoa from Abac Capital

PAI Partners Acquires Majority Stake in Uvesco

December 22, 2021

Retail

PAI Partners, via its PAI Mid-Market Fund, has signed an agreement to acquire a majority stake in Uvesco from the company’s current shareholders. The investment will support Uvesco’s organic store rollout and M&A-driven expansion across Northern Spain and Madrid while keeping the company headquartered in Guipúzcoa.

PAI Mid‑Market Fund (PAI MMF) Acquires Majority Stake in Angulas Aguinaga

November 9, 2020

Food & Beverage

PAI Partners, through its PAI Mid‑Market Fund (PAI MMF), has acquired a majority stake in Angulas Aguinaga, the Spanish leader in refrigerated fish and seafood convenience products, from Portobello Capital and the founding family. The existing shareholders will reinvest and retain a 49.9% stake; PAI will support the company's Strategic Plan 2020–2025, focusing on brand reinforcement, new product categories and international expansion (notably Italy and France).

PAI Partners Acquires Majority Stake in Nutripure

July 25, 2024

Consumer Products

PAI Partners, through its PAI Mid-Market Fund, has agreed to acquire a majority, controlling stake in Nutripure from Ardian. The investment will support Nutripure’s product development, community growth and European expansion while founders and Bpifrance remain shareholders.

PAI Partners Agrees to Acquire Majority Stake in ECF Group

June 14, 2023

Logistics & Distribution

PAI Partners has made a binding offer to acquire a majority stake in ECF Group from French private equity firm Naxicap Partners, with Naxicap remaining a minority investor alongside management. ECF is an omnichannel B2B distributor of equipment, consumables and hygiene products for hospitality and care professionals, headquartered in Grigny, France (~1,750 employees, ~€760m revenue); PAI intends to accelerate growth organically and via acquisitions to consolidate the fragmented market.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.

PAI Partners Acquires Apleona from EQT for ~€1.6bn

December 6, 2020

Industrial Services

PAI Partners has agreed to acquire Apleona Group GmbH from EQT (EQT VII) for approximately EUR 1.6 billion. Apleona, headquartered in Neu-Isenburg, Germany, is a leading European technical and integrated facility management provider with more than 20,000 employees and a strong position in the DACH region; PAI said it will pursue further consolidation and growth both organically and via M&A.